「validity」の検索結果

Post-writing SEO validation with pass/fail checklist covering title tag length and keyword placement, meta description quality, heading hierarchy and keyword density, internal/external link audit with anchor text analysis, canonical URL verification, Open Graph meta tags (og:title, og:description, og:image), Twitter Card validation, structured data presence and validity, URL structure optimization, and image alt text presence. Produces prioritized fix list with specific recommendations. Use when user says "seo check", "check seo", "validate seo", "blog seo", "seo validation", "on-page seo", "title tag check", "meta description check", "heading check", "link audit".

日本語の概要は準備中です。原文の説明を表示しています。

Write and harden reusable agent-loop specification documents for biomechanics, data science, and vailá coding work. Use when the user says `/preto-loop`, asks to write/create/forge/specify/document an agent loop, turn an iterative vailá task into an autonomous loop, make an overnight loop, or design a biomechanics, data-pipeline, markerless-tracking, testing, refactoring, or performance loop. Include external verification, scientific validity, GUI/CLI parity, reproducibility, memory, guardrails, and named terminal states. Do not use merely to repeat a fixed scheduled prompt, execute an existing loop, or create unrelated documents.

日本語の概要は準備中です。原文の説明を表示しています。

Design, implement, or audit a Change Advisory Board (CAB) process for Salesforce deployments: change classification (standard, normal, emergency), required approvals, deployment gate sequencing, and integration with external ITSM tooling. NOT for scoring how risky one release is - use admin/deployment-risk-assessment. NOT for executing or troubleshooting the deployment itself - use admin/change-management-and-deployment. Also covers: the CAB charter (membership, quorum, decision rights), the CAB decision record artefact and its linter, the change classification matrix, the deployOptions a CAB decision pins (checkOnly, testLevel, rollbackOnError, ignoreWarnings, runTests), the 10-day quick-deploy validity window, the deploy-window vs freeze-register check, and the emergency (ECAB) path with its mandatory retrospective.

日本語の概要は準備中です。原文の説明を表示しています。

Digital signatures and time stamps through Openapi - eIDAS-compliant electronic signatures (SES with OTP, qualified QES, e-seals, massive automatic signing) and qualified time stamping of documents. Use when the user needs a document signed electronically or time-stamped with legal validity.

日本語の概要は準備中です。原文の説明を表示しています。

Vehicle data through Openapi Automotive - look up cars, motorcycles, insurance and MOT status by license plate across Italy, UK, Germany, France, Spain, Portugal. Use for vehicle technical data and insurance validity checks by plate.

日本語の概要は準備中です。原文の説明を表示しています。

Verify data validity through Openapi Trust - email deliverability, mobile number HLR checks, IP reputation, URL safety scans, document-based identity verification (IDV). Use for anti-fraud validation of user-provided contact data and identities.

日本語の概要は準備中です。原文の説明を表示しています。

Simulate transcription factor perturbation effects on cell state in silico with CellOracle and Dynamo, and predict transcriptional responses to genetic perturbations with GEARS, scGen, and CPA. Covers the direction-not-magnitude principle, local-linear validity, the GRN/velocity error it inherits, baseline discipline (mean and additive baselines), and the validation gap. Use when predicting TF knockout or overexpression effects, ranking driver TFs for fate transitions, or planning perturbation experiments. For GRN construction see multiomics-grn; for experimental Perturb-seq see single-cell/perturb-seq.

日本語の概要は準備中です。原文の説明を表示しています。

Prioritizes rare-disease variants from trio/quad WES/WGS with de novo (DeNovoGear, Triodenovo), compound-heterozygous phasing (WhatsHap), mosaic VAF tiering, phenotype-driven ranking (Exomiser, Phen2Gene, AMELIE), ClinGen gene-disease validity gating, and ACMG SF v3.2 secondary findings reporting. Use when running diagnostic exome / genome pipelines, identifying candidate Mendelian disease genes, screening for incidental findings, or auditing VUS reclassification cycles. The ACMG/AMP classification framework (PVS1 decision tree, Pejaver PP3/BP4 calibration, Tavtigian point system) is in clinical-databases/acmg-classification.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates bivariate genetic correlation (rg) between traits from GWAS summary statistics or individual-level genotypes using cross-trait LDSC, HDL, LAVA, rho-HESS, GREML-bivariate, Popcorn, and HDL-L. Use when quantifying shared genetic architecture between two traits, screening MR validity before causal inference, distinguishing global from locus-level rg, estimating trans-ancestry rg, separating partial from full causation via LCV gcp, or producing a STROBE-MR-compliant cross-trait sensitivity battery. Cross-trait LDSC intercept absorbs sample overlap and is NOT a bias; HDL is biased under sample overlap above ~5%. High rg between exposure and outcome motivates CHP-aware MR sensitivity (CAUSE, LHC-MR).

日本語の概要は準備中です。原文の説明を表示しています。

Provides guidance on acceptable blood sampling conditions for primary aldosteronism screening when ideal early‑morning supine fasting conditions cannot be met. Triggers include when a clinician says “The patient wasn’t fasting/supine” or questions whether non‑ideal sampling affects screening validity.

日本語の概要は準備中です。原文の説明を表示しています。

[Planning] Use when you need to auto-review a plan for validity, correctness, and best practices — recursive: review, validate findings with why-review, fix validated findings, full re-review until no findings.

日本語の概要は準備中です。原文の説明を表示しています。

Audit a composer output against four hard checks before delivery — cite integrity, voice rules, word count, schema validity. Always invoked after the polisher (English) or humanizer-* (Arabic / Hebrew). Emits a VerificationReport Pydantic object; orchestrator branches on `overall_passed`. Target ≥0.9 score per run. Triggers automatically as the final composer sub-agent; not user-facing.

日本語の概要は準備中です。原文の説明を表示しています。

Econometrics skill for instrumental variables and treatment effect estimation. Activates when the user asks about: "instrumental variables", "IV estimation", "2SLS", "two-stage least squares", "endogeneity", "weak instruments", "first stage", "Sargan test", "overidentification", "propensity score matching", "PSM", "average treatment effect", "ATT", "LATE", "local average treatment effect", "endogenous regressor", "instrument validity", "工具变量", "两阶段最小二乘", "内生性", "弱工具变量", "倾向得分匹配", "平均处理效应", "处理效应", "局部平均处理效应"

日本語の概要は準備中です。原文の説明を表示しています。

- Build an entity-relationship link-analysis graph of an investigation — nodes, typed edges carrying source and confidence, aliases, and temporal validity — to expose shared infrastructure, bridging nodes and the real principal behind a [человек]. Use when an investigation has outgrown a list and needs a graph, or when asked how a set of people, companies and domains connect

日本語の概要は準備中です。原文の説明を表示しています。

Focused Signals scout for PostHog projects running A/B experiments. Watches running experiments for validity threats (sample ratio mismatch, multi-variant contamination, exposure stalls, mid-run flag mutations) and lifecycle drift (zombie experiments running long past their useful life, decided-but-still-running experiments, ended experiments whose flags still serve multiple variants). Emits findings only when they clear the confidence bar; otherwise writes durable memory and closes out empty. Self-contained peer in the signals-scout-* fleet — no dependencies on other skills.

日本語の概要は準備中です。原文の説明を表示しています。

Extract release order, carrier, consignee, pickup location, goods, and validity fields from delivery orders.

日本語の概要は準備中です。原文の説明を表示しています。

Simulate transcription factor perturbation effects on cell state in silico with CellOracle and Dynamo, and predict transcriptional responses to genetic perturbations with GEARS, scGen, and CPA. Covers the direction-not-magnitude principle, local-linear validity, the GRN/velocity error it inherits, baseline discipline (mean and additive baselines), and the validation gap. Use when predicting TF knockout or overexpression effects, ranking driver TFs for fate transitions, or planning perturbation experiments. For GRN construction see multiomics-grn; for experimental Perturb-seq see single-cell/perturb-seq.

日本語の概要は準備中です。原文の説明を表示しています。

Prioritizes rare-disease variants from trio/quad WES/WGS with de novo (DeNovoGear, Triodenovo), compound-heterozygous phasing (WhatsHap), mosaic VAF tiering, phenotype-driven ranking (Exomiser, Phen2Gene, AMELIE), ClinGen gene-disease validity gating, and ACMG SF v3.2 secondary findings reporting. Use when running diagnostic exome / genome pipelines, identifying candidate Mendelian disease genes, screening for incidental findings, or auditing VUS reclassification cycles. The ACMG/AMP classification framework (PVS1 decision tree, Pejaver PP3/BP4 calibration, Tavtigian point system) is in clinical-databases/acmg-classification.

日本語の概要は準備中です。原文の説明を表示しています。

Estimate bivariate genetic correlation (rg) between traits from GWAS summary statistics or individual-level genotypes using cross-trait LDSC, HDL, LAVA, rho-HESS, GREML-bivariate, Popcorn, and HDL-L. Use when quantifying shared genetic architecture between two traits, screening MR validity before causal inference, distinguishing global from locus-level rg, estimating trans-ancestry rg, separating partial from full causation via LCV gcp, or producing a STROBE-MR-compliant cross-trait sensitivity battery. Cross-trait LDSC intercept absorbs sample overlap and is NOT a bias; HDL is biased under sample overlap above ~5%. High rg between exposure and outcome motivates CHP-aware MR sensitivity (CAUSE, LHC-MR).

日本語の概要は準備中です。原文の説明を表示しています。

Analyse experiment results, run validity checks (SRM, exposure parity, data integrity, novelty/primacy), interpret causally, make a ship/iterate/kill decision against the pre-declared rule, and append to cumulative learnings. Forces honest readouts — strips significance claims from underpowered or peek-violating tests; never lets directional results masquerade as causal wins. Load when results exist, or when the user says "read out this experiment", "analyse the test", "did the test win", "interpret the results", "what did we learn", "ship or kill", or when the experimentation orchestrator routes here.

日本語の概要は準備中です。原文の説明を表示しています。

Write a rigorous, decision-grade experiment spec — falsifiable hypothesis, primary metric, guardrails, randomisation unit, exposure definition, method (A/B, holdout, switchback, quasi-experiment, MAB), MDE/duration plan, peek policy, validity threats, and pre-committed decision rule. Platform-agnostic. Load when the user has a candidate experiment and needs to spec it before launch, or says "spec this experiment", "write the test plan", "design this A/B test", "what's the hypothesis", "how big a sample do we need", "how long should we run this", "define the metrics for this test", or when the experimentation orchestrator routes here.

日本語の概要は準備中です。原文の説明を表示しています。

Simulate transcription factor perturbation effects on cell state in silico with CellOracle and Dynamo, and predict transcriptional responses to genetic perturbations with GEARS, scGen, and CPA. Covers the direction-not-magnitude principle, local-linear validity, the GRN/velocity error it inherits, baseline discipline (mean and additive baselines), and the validation gap. Use when predicting TF knockout or overexpression effects, ranking driver TFs for fate transitions, or planning perturbation experiments. For GRN construction see multiomics-grn; for experimental Perturb-seq see single-cell/perturb-seq.

日本語の概要は準備中です。原文の説明を表示しています。

Prioritizes rare-disease variants from trio/quad WES/WGS with de novo (DeNovoGear, Triodenovo), compound-heterozygous phasing (WhatsHap), mosaic VAF tiering, phenotype-driven ranking (Exomiser, Phen2Gene, AMELIE), ClinGen gene-disease validity gating, and ACMG SF v3.2 secondary findings reporting. Use when running diagnostic exome / genome pipelines, identifying candidate Mendelian disease genes, screening for incidental findings, or auditing VUS reclassification cycles. The ACMG/AMP classification framework (PVS1 decision tree, Pejaver PP3/BP4 calibration, Tavtigian point system) is in clinical-databases/acmg-classification.

日本語の概要は準備中です。原文の説明を表示しています。

Estimate bivariate genetic correlation (rg) between traits from GWAS summary statistics or individual-level genotypes using cross-trait LDSC, HDL, LAVA, rho-HESS, GREML-bivariate, Popcorn, and HDL-L. Use when quantifying shared genetic architecture between two traits, screening MR validity before causal inference, distinguishing global from locus-level rg, estimating trans-ancestry rg, separating partial from full causation via LCV gcp, or producing a STROBE-MR-compliant cross-trait sensitivity battery. Cross-trait LDSC intercept absorbs sample overlap and is NOT a bias; HDL is biased under sample overlap above ~5%. High rg between exposure and outcome motivates CHP-aware MR sensitivity (CAUSE, LHC-MR).

日本語の概要は準備中です。原文の説明を表示しています。